Macrophage Mitochondrial Oxidative Stress Promotes Atherosclerosis and Nuclear Factor-κB–Mediated Inflammation in Macrophages
Open Access
- 31 January 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 114 (3), 421-433
- https://doi.org/10.1161/circresaha.114.302153
Abstract
Rationale: Mitochondrial oxidative stress (mitoOS) has been shown to correlate with the progression of human atherosclerosis. However, definitive cell type–specific causation studies in vivo are lacking, and the molecular mechanisms of potential proatherogenic effects remain to be determined. Objective: Our aims were to assess the importance of macrophage mitoOS in atherogenesis and to explore the underlying molecular mechanisms. Methods and Results: We first validated Western diet–fed Ldlr−/− mice as a model of human mitoOS–atherosclerosis association by showing that non-nuclear oxidative DNA damage, a marker of mitoOS in lesional macrophages, correlates with aortic root lesion development. To investigate the importance of macrophage mitoOS, we used a genetic engineering strategy in which the OS suppressor catalase was ectopically expressed in mitochondria (mCAT) in macrophages. MitoOS in lesional macrophages was successfully suppressed in these mice, and this led to a significant reduction in aortic root lesional area. The mCAT lesions had less monocyte-derived cells, less Ly6chi monocyte infiltration into lesions, and lower levels of monocyte chemotactic protein-1. The decrease in lesional monocyte chemotactic protein-1 was associated with the suppression of other markers of inflammation and with decreased phosphorylation of RelA (NF-κB p65), indicating decreased activation of the proinflammatory NF-κB pathway. Using models of mitoOS in cultured macrophages, we showed that mCAT suppressed monocyte chemotactic protein-1 expression by decreasing the activation of the IκB-kinase β–RelA NF-κB pathway. Conclusions: MitoOS in lesional macrophages amplifies atherosclerotic lesion development by promoting NF-κB–mediated entry of monocytes and other inflammatory processes. In view of the mitoOS–atherosclerosis link in human atheromata, these findings reveal a potentially new therapeutic target to prevent the progression of atherosclerosis.Keywords
This publication has 62 references indexed in Scilit:
- Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCsJCI Insight, 2012
- The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaquesNature Immunology, 2012
- Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe–/– mice during disease regressionJCI Insight, 2011
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)The Journal of Experimental Medicine, 2011
- Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum StressCell Metabolism, 2010
- Does Oxidative DNA Damage Cause Atherosclerosis and Metabolic Syndrome?Circulation Research, 2010
- Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in miceJCI Insight, 2009
- Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJCI Insight, 2007
- Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaquesJCI Insight, 2007